The Department of Oncology at Wayne State University and the Karmanos Cancer Institute Molecular Imaging Program has open positions for a full time tenure track faculty member with a focus on cancer imaging and/or theranostics research. This position is at the Assistant, Associate, or Full Professor level. The KCI MI program is committed to the advancement of theranostics through agent and instrumentation development with the goal of translating these strategies to clinical application. We are interested in applicants who have Multidisciplinary experience that can be applied to the development of molecular imaging approaches and theranostics research for cancer management and response assessment. The qualified candidate should have a Ph.D., M.D. and/or M.D. Ph.D degree(s) with experience in molecular imaging and relevant fields and/or potential and trajectory. Candidates are expected to establish an independent research program and participate in our center-wide efforts to translate novel theranostic technologies into clinical practice. The ideal candidate is also expected to establish intra- and interprogrammatic collaborations within KCI’s four research programs, which includes Molecular Imaging, Tumor Biology and Microenvironment, Molecular Therapeutics, Population Studies and Disparities Research. The ideal candidate will have demonstrated breadth of preparation, as exemplified by significant clinical and/or research experience resulting in high impact publications in biomedical research. A successful candidate will be expected to obtain grant funding (e.g., NIH award(s)), and engage in multidisciplinary research. We are looking for motivated individuals who are committed to excellence in research, teaching, and mentoring of students in multi- disciplinary biomedical research.
Interested applicants may submit their cover letter, CV, teaching portfolio and research statement.
Applicants should apply for req235 using the following link:
Faculty - Rank to be Determined - Dept of Oncology.
The Barbara Ann Karmanos Cancer Institute (KCI) is an NCI-designated Comprehensive Cancer Center dedicated to the prevention, early detection, treatment and eventual eradication of cancer. The Institute is located near major hospital networks and the WSU School of Medicine, and several major art, cultural and sports venues in vibrant mid-town Detroit. Through the commitment of over 1,200 staff, including over 300 physicians and researchers and supported by thousands of volunteers and financial donors, Key to achieving its mission is KCI’s research effort, which is conducted through four interdisciplinary programs, organized to integrate basic, translational, clinical, and population research activities. Karmanos is the only hospital in Michigan dedicated exclusively to fighting cancer. Caring for approximately 12,000 new patients annually and conducting more than 800 cancer-specific clinical trials, the KCI is among the nation’s top cancer centers. Gerold Bepler, M.D., Ph.D., is the Institute’s President and Chief Executive Officer. More information can be found at www.karmanos.org. KCI is affiliated with Wayne State University (WSU), which has the largest single-campus medical school in the country. WSU is a Carnegie level 1 institution and a premier, public, urban research university located in the heart of Detroit where students from all backgrounds are offered a rich, high quality education. The WSU School of Medicine is located in midtown Detroit, one of the dynamic urban communities leading the revitalization of the city. The metropolitan area provides a cosmopolitan environment with rich cultural offerings, strong schools and outstanding affordable housing in our beautiful Great Lakes region. Our deeprooted commitment to excellence, collaboration, integrity, diversity and inclusion creates exceptional educational opportunities preparing students for success in a diverse, global society. WSU encourages applications from women, people of color, and other underrepresented people. WSU is an affirmative action/equal opportunity employer. All qualified applicants will receive consideration of employment without regard to race, color, religion, sex, national origin, age, disability, veteran status, or any other characteristic protected by law. Applications will be reviewed beginning May 1, 2023 and the position will remain open until filled.